T2 Biosystems Affirms Plans to Add Candida Auris Detection to the FDA-Cleared T2Candida Panel
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Mar 23
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to…
24 Mar 23
The newly available diagnostic test detects active COVID-19 and/or flu infection, with results available in as few as…
23 Mar 23
Roche and Lilly will jointly support the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel that enables early…
22 Mar 23
The algorithm, dubbed Viz AAA, leverages artificial intelligence to automatically search for an abdominal aortic aneurysm (AAA) in…
21 Mar 23
The current FDA approval expands Explorer Air II’s indication to include its use with Pafolacianine, an optical imaging…
21 Mar 23
The nucleic acid amplification test is now cleared for use in professional point-of-care settings in the US to…
20 Mar 23
In the two clinical trials, dubbed DERM-ASSESS 3 and DERM-SUCCESS, the device showed a 94% sensitivity in classifying…
20 Mar 23
Expansion of the advanced saliva collection tool that standardises samples through advanced filtered collection tip and eliminates common…
20 Mar 23
Choose Health's white label partners can choose from 28+ biomarkers to create customized test panels that are highly…
20 Mar 23
The base longevity at home test-kit, to be commercialized as early as of April 2023, measures intracellular NAD+…